Ars Pharmaceuticals, Inc. (SPRY) — DEF 14A Filings
All DEF 14A filings from Ars Pharmaceuticals, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
ARS Pharmaceuticals Files 2025 Proxy Statement
— Apr 29, 2025 Risk: low
ARS Pharmaceuticals, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting of stockholders scheduled for June 25, 2025. The filing -
ARS Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 26, 2024 Risk:
ARS Pharmaceuticals, Inc. (SPRY) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Annual Meeting scheduled for June 20, 2024, at 9:00 a.m. Paci
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX